With industry waiting on the FDA to issue regs for CBD products, the agency instead released a statement explaining why it has not yet done so—including fears that the trendy cannabinoid may cause liver damage. But advocates charge that the claim is based on faulty research.
Recent comments
1 week 13 hours ago
5 weeks 23 hours ago
6 weeks 1 day ago
6 weeks 1 day ago
27 weeks 2 days ago
31 weeks 3 days ago
33 weeks 4 hours ago
33 weeks 23 hours ago
45 weeks 3 days ago
51 weeks 1 day ago